Advertisement
  • When Cancer Becomes an Unwanted Priority

    Amanda Rose Ferraro’s leukemia diagnosis forced her to spend time at the hospital away from her 3-year-old-son. She calls focusing on her health and leaving her son “the hardest thing I have ever had to do.”

    by Amanda Rose Ferraro

  • New Drugs for an Elusive Cancer Target

    Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.

    by Anna Azvolinsky

  • Clinical Trials: An African American Survivor’s Experience

    Melvin Mann benefited from joining a pivotal clinical trial for chronic myelogenous leukemia, but participation came with logistical challenges.

    by Melvin Mann

  • “Congrats! You Have the ‘Good’ Cancer”

    Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

    by Carly Flumer

  • Telling Your Children About Inheritable Cancer Risk

    Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

    by Marci A. Landsmann

  • FROM THE EDITOR-IN-CHIEF

    Human Papillomavirus Vaccines: Bad News, Good News and Great News

    Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

    by William G. Nelson, MD, PhD

  • Turning Up the Heat on Cancer

    Researchers are working to expand the benefits of immunotherapy by making “cold” tumors “hot” so they can respond better to treatments.

    by Kendall K. Morgan

  • Secure Connections

    Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

    by Kate Yandell

  • BRCA: Who Should Be Tested?

    Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

    by Sue Rochman

  • Survivor Profile

    Handle With Care

    Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.

    by Lindsey Konkel

Advertisement

From the AACR

  • Cervical Cancer Awareness Month

    Cervical cancer now accounts for less than 1% of cancer-related deaths among women in the United States.

  • New FDA Approvals

    The first new anti-cancer therapeutics approved in 2020 are for the treatment of two different types of soft tissue sarcoma.

  • Imaging and Immunotherapy

    Imaging a patient’s cancer—and the responses generated by the immune system—can provide information that may guide treatment decisions.

Advertisement

Video

Follow My Lead

Advertisement

social media

donate to the AACR